Follow The Filings

CE Celanese Corporation

Materials, filed as CELANESE CORP DEL (COM), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

  • 2 Owners
  • Max 2.8%
  • $713M
  • 1 add 1 reduce

In 2026 Q2 Muhlenkamp & Co. added to Celanese, while Dodge & Cox trimmed.

Who owns this now

Largest portfolio weights among holders, up to 2.8% (Muhlenkamp & Co.). Not free-float ownership.

  1. Muhlenkamp & Co. Add 2.8%
  2. Dodge & Cox Reduce 0.37%

Who owns CE

Sorted by value, long equity only, as of 2026 Q2.

History
Dodge & Cox 0.37%, was 0.56% Reduce −0.4% 15,282,234 $703M History
Muhlenkamp & Co. 2.8% Add +0.6% 211,997 $9.8M History

2 current, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by CE's executives, directors and 10% owners in the last 12 months, from their Form 4s

All CE insider trades
  • $593K bought by 4 insiders
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. Chuck Kyrish CFO
    Buy
    $105K 2,300 shares at $45.52 +8.6% to stake
    Traded Aug 14 Filed Aug 17
    ↗
  2. Ashley B Duffie SVP & Gc
    Buy
    $27K 600 shares at $45.60 +1.9% to stake
    Traded Aug 11 Filed Aug 13
    ↗
  3. Mark Christopher Murray SVP - Acetyls
    Buy
    $98K 2,153 shares at $45.52 +7.6% to stake
    Traded Aug 11 Filed Aug 12
    ↗
  4. Scott A Richardson CEO
    Buy
    $158K 3,800 shares at $41.59 +5.7% to stake
    Traded Dec 10, 2025 Filed Dec 12, 2025
    ↗
  5. Chuck Kyrish CFO
    Buy
    $205K 5,000 shares at $41.03 +85% to stake
    Traded Dec 9, 2025 Filed Dec 11, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 23 stock grants, 6 share withholdings for taxes, 3 sales back to the company, and 1 conversion.

Congress

No member of Congress reported trading CE in the last three years. 1 member listed it in 2025 annual reports.

All Congress trades

SEC filings

Recent issuer filings from EDGAR, 19 shown.

Filed Form Detail Links
8-K/A 5.02 Filing Doc
8-K 5.02,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
10-Q Filing Doc
8-K 1.01,2.03,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 8.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G — Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G — Filing Doc
8-K 5.02,9.01 Filing Doc
8-K 5.07,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
DEFA14A Filing Doc

Source: SEC EDGAR submissions, updated 12 days ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $10.94B $10.28B $9.54B
Gross profit $2.6B $2.36B $1.95B
Gross margin * 23.8% 22.9% 20.5%
Net income $1.96B -$1.52B -$1.16B
Net margin * 17.9% -14.8% -12.2%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $6.22B $5.14B $5.69B
Total non-current assets * $20.38B $17.71B $16B
Total assets $26.6B $22.86B $21.7B
Total current liabilities $4.07B $3.85B $3.68B
Total equity $7.09B $5.18B $4.05B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $1.9B $0.966B $1.15B
Cash from investing -$134M -$470M -$349M
Cash from financing -$1.46B -$1.31B -$0.513B
Net change in cash $297M -$843M $301M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.